EtO Sterilization

Ensuring Patient Access

Proposals restricting the use of Ethylene Oxide (EtO) threaten the supply of critical medical technologies. We’re advocating for reasonable policies that balance risk, allowing innovators to deliver critical products to patients and providers.

A doctor wearing operating scrubs and a mask

20 Billion Devices

Approximately 20 billion devices (~50% of all devices) are sterilized annually with EtO

Product Shortage Concerns

Past and existing proposals limiting medical device EtO sterilization threatens public health and creates medical technology shortages

MDMA Advocacy

MDMA advocacy resulted in a more balanced NESHAP, and we continue to raise concerns over EPA’s PID proposal

a Policy With critical Real-world Impacts

The real-world impacts of certain policy proposals to restrict the use of EtO would be catastrophic for patients, providers, and innovators in this ecosystem. EtO is essential to healthcare delivery in the United States and around the world. MDMA worked with Congress and key stakeholders within the Administration to elevate FDA’s concerns that initial EPA EtO proposals would lead to shortages of critical medical devices. MDMA’s emerging chemicals advocacy and education seeks to limit supply chain disruptions and advocate for risk-based regulations.

Click here for the latest EtO news.